Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease (Q34002795)

30 July 2017

1 reference

title

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease (English)

1 reference

30 July 2017

0 references

Maelicke A

1 reference

30 July 2017

Schrattenholz A

1 reference

30 July 2017

Samochocki M

1 reference

30 July 2017

Radina M

1 reference

30 July 2017

Albuquerque EX

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Behavioural Brain Research

30 July 2017

published in

1 reference

30 July 2017

volume

113

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

199-206

1 reference

Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Cholinergic underactivity in human memory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Acetylcholinesterase inhibitors for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Sustained nicotine exposure differentially affects alpha 3 beta 2 and alpha 4 beta 2 neuronal nicotinic receptors expressed in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

NBD-5-acylcholine: fluorescent analog of acetylcholine and agonist at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotinic receptor function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Kinetic properties and regulation of GABAA receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Intravenous nicotine in Alzheimer's disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

A novel agonist binding site on nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Presynaptic muscarinic receptors in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Mapping of a Binding Site for ATP within the Extracellular Region of the Torpedo Nicotinic Acetylcholine Receptor β-Subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Progesterone modulates a neuronal nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Nicotine: not just for cigarettes anymore

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900214-X

7 January 2021

10.1016/S0166-4328(00)00214-X

Identifiers

DOI

1 reference

30 July 2017

1 reference